(Q40643273)

22 September 2017

Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777. (English)

1 reference

22 September 2017

1 reference

lymphoblastic leukemia

1 reference

Shanta Bantia

1

1 reference

22 September 2017

Sandya L Ananth

2

1 reference

22 September 2017

Cynthia D Parker

3

1 reference

22 September 2017

LaShun L Horn

4

1 reference

22 September 2017

Ramanda Upshaw

5

1 reference

22 September 2017

1 June 2003

1 reference

International Immunopharmacology

22 September 2017

1 reference

22 September 2017

3

1 reference

22 September 2017

6

1 reference

22 September 2017

879-887

1 reference

Biochemistry of Diseases of Immunodevelopment

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)--a novel potent and orally active immunosuppressive agent

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Comparison of in vivo efficacy of BCX-1777 and cyclosporin in xenogeneic graft-vs.-host disease: the role of dGTP in antiproliferative action of BCX-1777.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Allosteric regulation of calf thymus ribonucleoside diphosphate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

dNTP pools imbalance as a signal to initiate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

Regulation of the salvage pathway of deoxynucleotides synthesis in apoptosis induced by growth factor deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2803%2900076-6

7 January 2021

10.1016/S1567-5769(03)00076-6

Identifiers

DOI

1 reference

22 September 2017

1 reference